Drug Information
| Drug General Information | |||||
|---|---|---|---|---|---|
| Drug ID |
D08WRG
|
||||
| Former ID |
DNC013820
|
||||
| Drug Name |
3-(4-o-Tolylpiperazine-1-carbonyl)coumarin
|
||||
| Drug Type |
Small molecular drug
|
||||
| Indication | Discovery agent | Investigative | [529641] | ||
| Formula |
C21H20N2O3
|
||||
| Canonical SMILES |
CC1=CC=CC=C1N2CCN(CC2)C(=O)C3=CC4=CC=CC=C4OC3=O
|
||||
| InChI |
1S/C21H20N2O3/c1-15-6-2-4-8-18(15)22-10-12-23(13-11-22)20(24)17-14-16-7-3-5-9-19(16)26-21(17)25/h2-9,14H,10-13H2,1H3
|
||||
| InChIKey |
IVCTUFTWYWRJLW-UHFFFAOYSA-N
|
||||
| PubChem Compound ID | |||||
| Target and Pathway | |||||
| Target(s) | Acetylcholinesterase | Target Info | Inhibitor | [529641] | |
| KEGG Pathway | Glycerophospholipid metabolism | ||||
| Cholinergic synapse | |||||
| Pathway Interaction Database | ATF-2 transcription factor network | ||||
| PathWhiz Pathway | Phospholipid Biosynthesis | ||||
| References | |||||